Syringes and Injectable Drugs Packaging Market Size - By Product Type, By Material, By End Use - Global Forecast, 2025 - 2034

Syringes and Injectable Drugs Packaging Market Size

The global syringes and injectable drugs packaging market size was valued at USD 30.6 billion in 2024 and is estimated to grow at 13.3% CAGR from 2025 to 2034. The demand for syringes and injectable drugs packaging is increasing significantly due to the growth in demand for injectable drug delivery.
 

The Trump administration’s tariffs, particularly those levied on Chinese syringes and needles and the proposed higher tariffs on pharmaceuticals, are poised to increase costs, exacerbate shortages, and disrupt the supply chain for syringes and injectable drugs packaging in the U.S. While these measures aim to boost domestic manufacturing, the immediate effects will likely include higher healthcare costs and reduced access to critical medical supplies. The industry’s efforts to stockpile and lobby for phased tariffs may mitigate some impacts, but significant challenges remain, especially for low-margin generics and sterile injectables.
 

With the rise in infectious diseases globally the demand for the syringe and injectable drugs are growing which leads to the increase in demand for the syringes and injectable drugs packaging market. According to the World Health Organization (WHO), in 2023 the reported cases of infectious diseases worldwide was 249 million for Malaria, 10.8 million for Tuberculosis, etc. This reflects the demand for syringes and the utmost requirement for the packaging of the syringes and injectable drugs as they are directly introduced into the bloodstream or the body tissue and thus packaging plays a crucial role in preventing the microbial contamination.
 

The syringe and injectable drugs packaging makers are deliberately working towards the expansion of the manufacturing facilities and enhancing their capabilities in innovations which helps the manufacturers to navigate in the pharmaceutical landscape. For instance, in March 2024, Wilson, N.C. (AP) which makes containers for vaccines and other drugs established a new manufacturing plant and SCHOTT Pharma invested 371 million in the project in the Wilson production facility.
 

The vaccinations among the consumers has increased majorly and this has marked the rise in the syringes and injectable drugs packaging across the region. According to Statista, the revenue generated through vaccine was around USD 74.1 billion. This creates the demand for the packaging of the syringes which in turn leads to the growth of the syringe and injectable drugs packaging across the globe.
 

Syringes and Injectable Drugs Packaging Market Trends

• The growing case of diabetes is leading to the growth of prefilled syringes and insulin injectors packaging solutions. According to the International Diabetes Federation Diabetes Atlas report 2025, 11.1% of the adult population (20-79 years) have diabetes. This reflects the growing conditions for the safety and prevention of the injectable drugs and syringe through efficient packaging, ensuring leak-proof and protection from the contamination of the drugs.
   
• There is a rising trend of sustainable and eco-friendly packaging materials which includes the use of biodegradable packaging options with the focus to reduce the adverse impact of the environment. The study shows that more than 8 million tons of pandemic-associated waste was generated and around 25,000 tons of waste entered the ocean. This puts the pressure on the manufacturers and packaging solution providers to cater the packaging needs of the pharmaceutical such as drugs and syringes and protect the environment from getting polluted.
   

Syringes and Injectable Drugs Packaging Market Analysis

Based on product type, the market is divided into syringes and injectable drugs packaging.
 

• The syringes in the market is anticipated to reach USD 54.2 billion by 2034. Due to growing concerns of the infections related issues, there is a shift in the market towards infection-preventive packaging solutions in areas such as hospitals and home-care settings. For instance, in May 2023, BD launched its prefilled flush syringe equipped with disinfection unit for the enhancement of the patient safety. This reflects the growth of the packaging solutions in the syringes.
   
• The injectable drugs packaging market was valued at USD 16.3 billion in the year 2024. The increasing adoption of prefilled and ready to use formats has created the demand for packaging solutions of the injectable drugs. The aim revolves around enhancing the drugs preventions from contaminations and with the rise in speciality drugs, the need for high barrier drug packaging is growing significantly.

Based on material type, the syringes and injectable drugs packaging market is divided into plastic glass and others.
 

• The plastic market is projected to reach USD 42.5 billion by 2034. The plastics are in demand owing to their lightweight, break-resistant, and design-flexibles properties, particularly in prefilled injectors. For instance, in January 2025, West Pharmaceutical Services, Inc., introduced the Daikyo PLASCAP Ready-to-Use Validated (RUV) closures in new nested format. It is compatible with vials of 13mm and 20 mm crown. With such innovation and demand, the market is expecting to witness growth of the plastic such as polypropylene caps.
   
• The glass segment held a market share of 57.4% in 2024. The glass segment is in demand as it possesses efficient barrier properties. Companies are using glass to produce high quality vials, syringes, cartridges to store simple and complex drugs. For instance, in October 2023, SCHOTT AG launched its FIOLAX Pro glass tubing which is a new type I borosilicate glass which was designed to meet the needs of the pharma industry. This showcases the growing adoption of the glass materials in forming packaging solutions for the syringe and injectable drugs.
   

Based on end-user, the syringes and injectable drugs packaging market is divided into hospitals and clinics, Ambulatory Surgical Centers (ASCs), pharmaceutical & biotechnology companies, home healthcare settings, and vaccination centers.
 

• The hospitals and clinics market is projected to grow at a CAGR of 14.2% by 2034. The hospitals and clinics are focusing on the improvement of the safety of the syringes and injectables drugs uses. There is a push for the demand of packaging solution which ensures the preventive measures in compliances with the regulatory standards. The rising demand from the healthcare institutions is paving the path for the growth of the syringe and injectables drugs packaging market.
   
• The pharmaceutical & biotechnology companies accounted for 41% market share in 2024. The companies are coming forward to develop packaging solutions for the syringes and injectables drugs. Pharma companies are investing in drug delivery device manufacturing. For instance, in September 2024, PCI Pharma invested more than USD 365 million in the infrastructure for the support in assembly and packaging effort. With the increasing requirement from pharmaceutical and biotechnology companies there is significant growth in the syringe and injectable drugs packaging market.

North America syringes and injectable drugs packaging market held 39% share in 2024. North America has a strong regional base of pharmaceutical and biologics. With the advanced healthcare infrastructure, the region witness growth in the market. The demand for prefilled and syringes are increasing in North America with the major focus on safety and compliance leading to the adoption of advanced materials in syringes packaging to meet the compliances requirements.
 

• The U.S. syringes and injectable drugs packaging market is projected to reach USD 33.2 billion by 2034. The growing chronic medical condition in the U.S. highlights the demand for the syringes and injectable drugs. According to Statista, the number of individuals with chronic diseases is expected to reach around 171 million. The demand of proper packaging solutions is rising to help protect the syringes from getting contaminated. 
   
• Canada syringes and injectable drugs packaging market is expected to grow at a CAGR of 14.8% by 2034. The growing focus on sustainability has led to the adoption of recyclable and biodegradable options for the syringes and injectable drugs packaging. The country embraces the changing landscape of pharmaceutical industry and Canada is actively enhancing its role in syringes and injectable drugs packaging so that the patient is safe from exposure to contaminated syringes and drugs.
   

Europe syringes and injectable drugs packaging market held a significant share of 28.3% in 2024. The Europe is witnessing growth in the syringes and injectable drugs market. With the expansion of the biopharmaceutical manufacturing, there is rise in demand for sterile, high-barrier packaging solutions. Europe is strengthening its capabilities with the increase in demand for advanced primary packaging formats, which includes coated glass and cyclic olefin polymers (COP) for biologics.
 

• Germany syringes and injectable drugs packaging market is expected to grow at a CAGR of 12.9% by 2034. The healthcare industry in Germany witness demand for the syringes and injectable drugs packaging as the country focuses on improving the medical facilities with its focus on implementing sustainable packaging materials. Germany invests in technology and adheres with the EU regulation for the purpose of maintaining safety of the patients. With the growing infectious diseases, the country actively participates in developing solution that prevents the syringes and drugs from getting contaminated. 
   
• The UK syringes and injectable drugs packaging market is expected to grow at a CAGR of 13.4% by 2034. The United Kingdom’s is witnessing the growth in adoption of prefilled syringes, particularly for biologics and chronic diseases. The country has stringent regulations which focuses on patient’s safety as well the environment and thus creates the demand for packaging solutions in the syringes and injected drugs market.
   
• France syringes and injectable drugs packaging industry is expected grow at a CAGR of 12.6% by 2034. To adhere with the medication safety doses for the patient, there is requirement of syringes packaging within the country. With the increasing adoption of unit-doses, blister packs are in demand which reflects the rising shift towards sustainable packaging solutions.
   
• Italy syringes and injectable drugs packaging market accounted for 11.4% of the share in 2024. With the growing counterfeiting in the pharmaceutical industry, the country witnesses growth in the packaging solutions with safety features such as tamper-evident seals and other related solutions in the syringes and injectable drugs so that there is safety of the patient.
   

Asia Pacific market is projected to grow at a strong pace with a CAGR of 14.2% by 2034. A rapid transition to sustainable packaging solutions in the syringes and injectable drugs has led to the growth of the market within the Asia Pacific region. The increasing production of biologics and biosimilars generates demand for specialized packaging solutions. The Asia Pacific region is prone to chronic diseases and thus the demand for the syringes is high for the curing purpose. This reflects the growth of the packaging solutions which are in need for the syringes and injectable drugs.
 

• China syringes and injectable drugs packaging market accounted for 37.7% of the market share in 2024. With the rising health awareness among the consumers the demand for syringes and injectable drugs packaging are rising in China. The drug delivery devices are actively used to cure the patients with certain diseases. According to Statista, the revenue generated by the drug delivery devices in China was around USD 3.2 billion in the year 2024 and is expected to grow and reach a value of USD 4.5 billion by the year 2029. With such demand the packaging need also gains tractions in China.
   
• The syringes and injectable drugs packaging market in India is anticipated to grow at a CAGR of 14.7% by 2034. The rise in chronic diseases, and with the growing demand for biopharmaceuticals and advancement in the packaging technologies, the demand for the syringes and injectables drugs packaging is growing significantly in India.
   
• Japan market held a share of 13.5% in 2024. Japan’s aging population has increased the focus of the country to develop the healthcare facilities and with the increase in chronic or other diseases, the country is fuelling the demand for the injectable drug delivery systems and for this there is rise in demand for the packaging solutions for the purpose of maintaining safety of the syringes and drugs.
   

Latin America held a share of 5.8% of the syringes and injectable drugs packaging market in 2024. The rising cases of diseases such as diabetes, cardiovascular and other prevailing infectious diseases, the region is creating the demand of syringes and injectable drugs with proper safety packaging closures to prevent the patent’s contamination with the infected syringes. This reflects the demand of the packaging solution in the Latin America, ensuring the reduced risk of contaminations.
 

Middle East & Africa syringes and injectable drugs packaging market is projected to grow at a strong pace with a CAGR of 8.9% by 2034. syringes and injectable drugs packaging is growing in the MEA region due to the growing health issues among the people in the region. According to the International Diabetes Federation, Africa is set to register the highest increase in the number of people with diabetes of all regions by the year 2045. This highlights the growth of the packaging and preventive solutions which are in need for the patient’s safety.
 

Syringes and Injectable Drugs Packaging Market Share

The market is highly competitive. The top 5 players in the market are BD, Gerresheimer, Schott AG, West Pharmaceutical Services, Inc., and Nipro Europe Group Companies accounting for a significant share of over 52.8% in the market. Syringes and injectable drugs packaging companies are implementing different strategies to enhance their market position and address changing consumer needs. Major players are investing in materials for packaging of the syringes and injectable drugs, such as polypropylene, Polycarbonate (PC), etc.
 

The companies are forming strategic alliance to develop the packaging solutions for the syringes and injectable drugs. For instance, in September 2024, SCHOTT Pharma, Stevanato Group, and Gerresheimer came into collaboration to support the adoption of ready-to-use (RTU) vials and cartridges. The main goal encircles the patient’s safety with high-quality sterile primary packaging.
 

Syringes and Injectable Drugs Packaging Market Companies

Some of the prominent market participants operating in the syringes and injectable drugs packaging industry include:
 

• BD
• Gerresheimer
• Schott AG
• West Pharmaceutical Services, Inc.
• Nipro Europe Group Companies
   

BD is committed towards drug delivery excellence. The company possesses 50 years of experience. It has innovative design, product development expertise and global manufacturing units. The company manufactures more than 3 billion Prefillable Syringes (PFS). The strong research and development team helps the company in forming innovative solutions.
 

Schott AG focuses on bringing specialized packaging solutions for the syringes and injectable drugs. The company provides reliable and scalable packaging solutions for the pharmaceutical industry. Schott AG strategically forms partnership to leverage the expertise and provide innovative packaging solutions.
 

Syringes and Injectable Drugs Packaging Industry News

• In October 2024, SCHOTT Pharma in partnership with Schreiner MediPharm and Körber Pharma developed new packaging concept for prefilled syringes which helps in the reduction of plastic and packaging waste.
   
• In June 2024, Sharp Services announced the expansion in Pennsylvania to facilitate the growth of production capacity for sterile injectables secondary packaging.
   

The syringes and injectable drugs packaging market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue (USD Billion) from 2021 to 2034, for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Syringes
  • Prefilled syringes
  • Conventional syringes 
• Injectable drugs packaging
  • Vials
  • Ampoules
  • Cartridges
  • Bottles

Market, By Material Type

• Plastic
  • Polypropylene (PP)
  • Polyethylene (PE)
  • Polycarbonate (PC)
  • Others 
• Glass
• Others

Market, By End Use

• Hospitals and clinics
• Ambulatory surgical centers (ASCs)
• Pharmaceutical & biotechnology companies
• Home healthcare settings
• Vaccination centers

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE